Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old
Clinical trial NCT05158777 · COMPLETED
Trial details
- NCT number
- NCT05158777
- Sponsor
- Shanghai Institute Of Biological Products
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-13
- Primary completion
- 2022-11-14
- Enrollment
- 2480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.